DRIO (DarioHealth) Minority Interest : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is DarioHealth Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

DarioHealth's minority interest for the quarter that ended in Sep. 2024 was $0.00 Mil.

DarioHealth Minority Interest Historical Data

The historical data trend for DarioHealth's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DarioHealth Minority Interest Chart

DarioHealth Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Minority Interest

Get a 7-Day Free Trial

DarioHealth Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Minority Interest	Get a 7-Day Free Trial															-	-	-	-	-

DarioHealth Minority Interest Calculation

DarioHealth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DarioHealth Corp (NAS:DRIO) » Definitions » Minority Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

322 W. 57th Street, New York, NY, USA, 10011

Website

https://www.mydario.com

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Executives

Erez Raphael	director, officer: Chief Executive Officer	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Jon H. Kaplan	director	1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Dennis M Mcgrath	director	C/O PAVMED INC., ONE GRAND CENTRAL PLACE, STE. 4600, NEW YORK NY 10165
Dror Bacher	officer: Chief Operating Officer	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK L3 3088900
Oded Cohen	officer: GM MSK	8 HATOKHEN ST., CAESAREA INDUSTRIAL PARK L3 3088900
Adam K Stern	director	STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019
Dennis Matheis	director	8 HATOKHEN ST., CAESAREA L3 38900
Yoav Shaked	director	8 HATOKHEN ST., CAESAREA L3 3088900
Yadin Shemmer	director	8 HATOKHEN ST., CAESAREA L3 3088900
Richard Allan Anderson	officer: President, GM of North America	C/O DARIOHEALTH CORP., 18 W. 18TH ST, 5TH FLOOR, NEW YORK NY 10011
Yalon Farhi	director	C/O LABSTYLE INNOVATIONS CORP., 9 HALAMISH ST., CAESAREA INDUSTRIAL PARK, CAESAREA L3 3088900
Hila Karah	director	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Zvi Ben-david	officer: Chief Financial Officer	9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Glen Moller	director	8 HATOKHEN ST., CAESAREA L3 3088900
Olivier Roger Jarry	officer: See Remarks	15 ROCKRIDGE RD, LARCHMONT NY 10538-3918